Congress trades

Amedisys, Inc. (AMED)

No longer trading under AMED.

5 Congress tradeslast filed Sep 12, 2025

Share
Download on the App StoreGet it on Google Play

Free on iOS and Android

Scan to get
the app

On recordAs of Nov 16, 2026

Amedisys no longer trades under AMED.

The filings below run to Sep 12, 2025.

EarningsQ2 FY2025 · reported Jul 29, 2025

Q2 FY2025: Beat on EPS. Revenue missed by 2.2%.

EPS Q2 FY2025

Reported$1.54
Consensus$1.39

Revenue Q2 FY2025

Reported$622M
Consensus$636M

Beat 4Miss 2

Every quarter

CongressSTOCK Act disclosures to the House and Senate

5 Congress disclosures shown, from 2 members.

25dMedian delayof the 45 day limit
3 buys · 2 sellsPurchases and sales in the disclosures shown
Every Congress trade in AMEDEvery disclosure
Companyfrom the company's filings and listing, as of Nov 15, 2026

About Amedisys, Inc.

Exchange
NASDAQ
Sector
Healthcare
Industry
Medical - Care Facilities
Chief executive
-
Employees
19,000
Listed since
Aug 17, 1994
Market value
$3.3Blast quoted Aug 14, 2025
Price to earnings (12 mo)
-
Net income per share, as reported (12 mo)
-
Dividend yield
-

www.amedisys.com

Earnings6 reported quarters

Earnings

QuarterEPSEPS expectedRevenueRevenue expectedResult
Q2 FY2025reported Jul 29, 2025$1.54$1.39$621.9M$635.8MEPS beatRevenue miss
Q1 FY2025reported Apr 23, 2025$1.25$1.13$594.8M$612.0MEPS beatRevenue miss
Q4 FY2024reported Feb 26, 2025$0.96$1.05$598.1M$602.4MEPS missRevenue in line
Q3 FY2024reported Nov 6, 2024$1.00$1.17$587.7M$596.4MEPS missRevenue in line
Q2 FY2024reported Jul 24, 2024$1.32$1.22$591.2M$578.8MEPS beatRevenue beat
Q1 FY2024reported Apr 24, 2024$1.03$1.01$571.4M$565.4MEPS beatRevenue in line

Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.

STOCK Act5 disclosures of 5 on record · median 25d of the 45 allowed

Congress trades in AMED

MemberTypeActionAmount disclosedSince the tradeTrade dateDisclosedDelay
Lisa C. McClainSpouseStockSale$1,001 - $15,000n/aPrice history ends Aug 14, 2025Aug 18, 2025Sep 12, 202525d
Lisa C. McClainSpouseStockPurchase$1,001 - $15,000n/aPrice history ends Aug 14, 2025Jun 9, 2025Aug 13, 202565d
Ro KhannaStockSale$1,001 - $15,000n/aPrice history ends Aug 14, 2025Mar 14, 2023Apr 7, 202324d
Ro KhannaStockPurchase$1,001 - $15,000n/aPrice history ends Aug 14, 2025Feb 10, 2023Mar 3, 202321d
Ro KhannaStockPurchase$1,001 - $15,000n/aPrice history ends Aug 14, 2025Jan 11, 2023Feb 7, 202327d

We hold no closing prices for any row shown here, so no move is shown. Not investment advice.

A delay above 45 days is the gap between the dates on the report; we mark a filing late only after checking it.

Every Congress trade in AMED filterable by party, chamber, type and account.

Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.

A STOCK Act disclosure gives each trade as a band of dollar values, which we do not narrow, and is due within 45 days of the trade. An option is described by its underlying company's name; its row says it is an option.

Data as of Nov 16, 2026.

Methodology · Guide to Form 4 · Guide to the STOCK Act

Questions

What the filings on AMED show and how current they are.

Which members of Congress have traded AMED?

Lisa C. McClain and Ro Khanna disclosed AMED transactions in the filings shown here.

How quickly are AMED trades disclosed?

Congressional disclosures took a median of 25 days, against the 45 the STOCK Act allows.

Related companies

traded by the same members

See every company we track